Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine vs Amlodipine in Obesity Related Hypertension
NCT04474899Phase 4Unknown
- Sponsor
- Royal Perth Hospital
- Start
- Jun 2015
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of moxonidine in hypertension (HTN), obesity, sponsored by Royal Perth Hospital. Status: unknown.
02
Drugs
moxonidine
03
Conditions
hypertension (HTN)obesity
Beyond the preview
Go deeper on NCT04474899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04474899.